NLS PHARMACEUTICS LTD

CUSIP: H57830111 Class: *W EXP 02/02/202

ARMISTICE CAPITAL, LLC's Holding History (CIK: 0001601086)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 12,500 Value ($000) $0 Avg Close Range
Q1 2025
Shares 12,500 Value ($000) $0 Avg Close Range
Q4 2024
Shares 12,500 Value ($000) $0 Avg Close Range
Q3 2024
Shares 12,500 Value ($000) $0 Avg Close Range
Q2 2024
Shares 500,000 Value ($000) $17 Avg Close Range
Q1 2024
Shares 500,000 Value ($000) $25 Avg Close Range
Q4 2023
Shares 500,000 Value ($000) $28 Avg Close Range
Q3 2023
Shares 500,000 Value ($000) $53 Avg Close Range
Q2 2023
Shares 500,000 Value ($000) $54 Avg Close Range
Q1 2023
Shares 500,001 Value ($000) $75 Avg Close Range
Q4 2022
Shares 500,000 Value ($000) $145 Avg Close Range
Q3 2022
Shares 500,000 Value ($000) $125 Avg Close Range
Q2 2022
Shares 500,000 Value ($000) $60 Avg Close Range
Q1 2022
Shares 500,000 Value ($000) $190 Avg Close Range
Q4 2021
Shares 500,000 Value ($000) $250 Avg Close Range
Q3 2021
Shares 500,000 Value ($000) $413 Avg Close Range
Q2 2021
Shares 500,000 Value ($000) $452 Avg Close Range
Q1 2021
Shares 500,000 Value ($000) $475 Avg Close Range